Update: Drug susceptibility of swine-origin influenza a (H1N1) viruses, April 2009

Morbidity and Mortality Weekly Report

Volumn 58, Issue 16, 2009, Pages 433-435

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; M2 PROTEIN, INFLUENZA A VIRUS; MATRIX PROTEIN; VIRUS RNA;

ANTIVIRAL RESISTANCE; ARTICLE; DRUG EFFECT; GENETICS; HUMAN; IC 50; INFLUENZA; INFLUENZA VIRUS A H1N1; ISOLATION AND PURIFICATION; MUTATION; UNITED STATES;

ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; INHIBITORY CONCENTRATION 50; MUTATION; RNA, VIRAL; UNITED STATES; VIRAL MATRIX PROTEINS;

EID: 65349186033     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. CDC. Swine influenza A (H1N1) infection in two children-southern California, March-April 2009. MMWR 2009;58:400-2.
2. Bright RA, Medina MJ, Xu X, et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 2005;366:1175-81.
3. Deyde VM, Xu X, Bright RA, et al. Surveillance of resistance to adamantanes among influenza A (H3N2) and A (H1N1) viruses isolated worldwide. J Infect Dis 2007;196:249-57.
4. Sheu TG, Deyde VM, Okomo-Adhiambo M, et al. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide in 2004-2008. Antimicrob Agents Chemother 2008;52:3284-92.
5. Lackenby A, Hungnes O, Dudman SG, et al. Emergence of resistance to oseltamivir among influenza A (H1N1) viruses in Europe. Euro Surveill 2008;13(5).
6. Deyde VM, Okomo-Adhiambo M, Sheu TG, et al. Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses. Antiviral Res 2009;81:16-24.
7. Lackenby A, Democratis J, Siqueira MM, Zambon MC. Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies. Antivir Ther 2008;13:809-20.
8. Hayden FG. Adamantadine and rimantadine-clinical aspects. In: DD Richman, ed. Antiviral drug resistance. San Francisco, CA: John Wiley and Sons Ltd.; 1996:59-77.
9. CDC. Influenza activity-United States and worldwide, 2007-08 season. MMWR 2008;57:692-7.
10. He G, Qiao J, Dong C, He C, Zhao L, Tian Y. Amantadine-resistance among H5N1 avian influenza viruses isolated in northern China. Antiviral Res 2008;77:72-6.
11. Cheung CL, Rayner JM, Smith GJ, et al. Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J Infect Dis 2006;193:1626-9.
12. Krumbholz A, Schmidtke M, Bergmann S, et al. High prevalence of amantadine resistance among circulating European porcine influenza A viruses. J Gen Virol 2009;90(Pt 4):900-8.
13. Schmidtke M, Zell R, Bauer K, et al. Amantadine resistance among porcine H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany between 1981 and 2001. Intervirology 2006;49:286-93.
14. Gregory V, Lim W, Cameron K, et al. Infection of a child in Hong Kong by an influenza A H3N2 virus closely related to viruses circulating in European pigs. J Gen Virol 2001;82(Pt 6):1397-406.
15. Bright RA, Shay DK, Shu B, Cox NJ, Klimov AI. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA 2006;295:891-4.
16. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005;353:1363-73.
17. Smith BJ, McKimm-Breshkin JL, McDonald M, Fernley RT, Varghese JN, Colman PM. Structural studies of the resistance of influenza virus neuramindase to inhibitors. J Med Chem 2002;45:2207-12.
18. Colman PM. Zanamivir: an influenza virus neuraminidase inhibitor. Expert Rev Anti Infect Ther 2005;3:191-9.
19. Monto AS, McKimm-Breschkin JL, Macken C, et al. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 2006;50:2395-402.
20. Dharan NJ, Gubareva LV, Meyer JJ, et al. Infections with oseltamivir-resistant influenza A (H1N1) virus in the United States. JAMA 2009;301:1034-41.
21. Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O. Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08. Emerg Infect Dis 2009;15:155-62.
22. Meijer A, Lackenby A, Hungnes O, et al. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg Infect Dis 2009;15:552-60.
23. Besselaar TG, Naidoo D, Buys A, et al. Widespread oseltamivir resistance in influenza A viruses (H1N1), South Africa. Emerg Infect Dis 2008;14:1809-10.